FDA Drug Recalls

Recalls / Class I

Class ID-0958-2016

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

Dextrose Injection,USP,70% 2000 mL VIAFLEX Plastic Container Bag, Pharmacy Bulk Package, Not For Direct Infusion, Must Be Diluted, Rx Only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-0719-06

Brand name
Dextrose
Generic name
Dextrose Monohydrate
Active ingredient
Dextrose Monohydrate
Route
Intravenous
NDC
0338-0719
FDA application
NDA020047
Affected lot / code info
Lot # C985150; Exp. 07/16

Why it was recalled

Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in the primary container of each product.

Recalling firm

Firm
Baxter Healthcare Corp.
Manufacturer
Baxter Healthcare Corporation
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1 Baxter Pkwy, N/A, Deerfield, Illinois 60015-4625

Distribution

Quantity
28,080 VIAFLEX Plastic Containers
Distribution pattern
Nationwide

Timeline

Recall initiated
2015-12-15
FDA classified
2016-06-06
Posted by FDA
2016-06-15
Terminated
2022-04-15
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0958-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.